Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cable, W.J.L.
Right arrow Articles by Adams, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cable, W.J.L.
Right arrow Articles by Adams, R. D.
NEUROLOGY 1982;32:498
© 1982 American Academy of Neurology

Fabry disease

Impaired autonomic function

W.J.L. Cable, E. H. Kolodny and R. D. Adams

Department of Biochemistry and Clinical Unit of the Eunice Kennedy Shriver Center for Mental Retardation, Inc., at the W. E. Fernald State School, Waltham, MA, and the Department of Neurology, Massachusetts General Hospital (Drs. Cable, Kolodny, and Adams) and Harvard Medical School (Drs. Kolodny and Adams), Boston, MA.

Previous reports of extensive lipid accumulation within neurons of the autonomic nervous system in Fabry disease suggest an anatomicopathologic basis for the peculiar pain, diminished sweating, and gastrointestinal symptoms experienced in this disorder. To further assess autonomic function in Fabry disease, noninvasive clinical tests were performed on 10 patients. Diminished sweating was found in each; the loss was approximately uniform proximally and distally, suggesting sweat gland dysfunction rather than autonomic neuropathy. Impaired pupillary constriction with pilocarpine, and reduced saliva and tear formation were found in half the patients. Disordered intestinal mobility was demonstrated in the oldest patients. In all cases, the cutaneous flare response to scratch and intradermal histamine was diminished, and pruritus was not experienced. Signs of autonomic dysfunction are present in Fabry disease and correlate with the known lipid deposition in autonomic neurons.

Address correspondence and reprint requests to Dr. Cable, Eunice Kennedy Shriver Center, 200 Trapelo Road, Waltham, MA 02154.

This investigation was supported in part by NIH grants Nos. HD05515, HD04147, and HD07164.

Presented in part at the thirty-second annual meeting of the American Academy of Neurology, New Orleans, LA, May 1980.

Accepted for publication September 29, 1981.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
R. Schiffmann, H. Askari, M. Timmons, C. Robinson, W. Benko, R. O. Brady, and M. Ries
Weekly Enzyme Replacement Therapy May Slow Decline of Renal Function in Patients with Fabry Disease Who Are on Long-Term Biweekly Dosing
J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1576 - 1583.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
M. Ries, J. T.R. Clarke, C. Whybra, M. Timmons, C. Robinson, B. L. Schlaggar, G. Pastores, Y. H. Lien, C. Kampmann, R. O. Brady, et al.
Enzyme-Replacement Therapy With Agalsidase Alfa in Children With Fabry Disease
Pediatrics, September 1, 2006; 118(3): 924 - 932.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Barbey, N. Brakch, A. Linhart, N. Rosenblatt-Velin, X. Jeanrenaud, S. Qanadli, B. Steinmann, M. Burnier, T. Palecek, J. Bultas, et al.
Cardiac and Vascular Hypertrophy in Fabry Disease: Evidence for a New Mechanism Independent of Blood Pressure and Glycosphingolipid Deposition
Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 839 - 844.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. Schiffmann, M. Ries, M. Timmons, J. T. Flaherty, and R. O. Brady
Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting
Nephrol. Dial. Transplant., February 1, 2006; 21(2): 345 - 354.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
M. Larralde, P. Boggio, H. Amartino, and N. Chamoles
Fabry Disease: A Study of 6 Hemizygous Men and 5 Heterozygous Women With Emphasis on Dermatologic Manifestations
Arch Dermatol, December 1, 2004; 140(12): 1440 - 1446.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin. Proc.Home page
T. M. Burns, M. M. Ryan, B. Darras, and H. R. Jones Jr
Current Therapeutic Strategies for Patients With Polyneuropathies Secondary to Inherited Metabolic Disorders
Mayo Clin. Proc., July 1, 2003; 78(7): 858 - 868.
[Abstract] [PDF]


Home page
QJMHome page
A. MEHTA
New developments in the management of Anderson-Fabry disease
QJM, October 1, 2002; 95(10): 647 - 653.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Bickel, H. H. Kramer, M. J. Hilz, F. Birklein, B. Neundorfer, and M. Schmelz
Assessment of the neurogenic flare reaction in small-fiber neuropathies
Neurology, September 24, 2002; 59(6): 917 - 919.
[Abstract] [Full Text] [PDF]


Home page
The Journal of the Royal Society for the Promotion of HealthHome page
A. K. C. Leung, H. Y. H. Cho, M. C. K. Choi, and P. Y. H. Chan
Hypohidrosis in children
Perspectives in Public Health, June 1, 1999; 119(2): 101 - 107.
[Abstract] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
W. E. Reichman and J. L. Cummings
Diagnosis of Rare Dementia Syndromes: An Algorithmic Approach
J Geriatr Psychiatry Neurol, April 1, 1990; 3(2): 73 - 84.
[Abstract] [PDF]


Home page
Arch NeurolHome page
T. Mutoh, Y. Senda, K. Sugimura, Y. Koike, Y. Matsuoka, I. Sobue, A. Takahashi, and M. Naoi
Severe Orthostatic Hypotension in a Female Carrier of Fabry's Disease
Arch Neurol, April 1, 1988; 45(4): 468 - 472.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by AAN Enterprises, Inc.